VIM1_XENLA
ID VIM1_XENLA Reviewed; 458 AA.
AC P24789; Q5U486; Q68EZ6;
DT 01-MAR-1992, integrated into UniProtKB/Swiss-Prot.
DT 01-MAR-1992, sequence version 1.
DT 03-AUG-2022, entry version 96.
DE RecName: Full=Vimentin-1/2;
GN Name=vim1;
GN and
GN Name=vim2;
OS Xenopus laevis (African clawed frog).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Amphibia;
OC Batrachia; Anura; Pipoidea; Pipidae; Xenopodinae; Xenopus; Xenopus.
OX NCBI_TaxID=8355;
RN [1]
RP NUCLEOTIDE SEQUENCE [MRNA].
RC TISSUE=Embryo;
RX PubMed=2806127; DOI=10.1242/dev.105.2.279;
RA Herrmann H., Fouquet B., Franke W.W.;
RT "Expression of intermediate filament proteins during development of Xenopus
RT laevis. I. cDNA clones encoding different forms of vimentin.";
RL Development 105:279-298(1989).
RN [2]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (VIM1 AND VIM2).
RC TISSUE=Kidney, and Spleen;
RG NIH - Xenopus Gene Collection (XGC) project;
RL Submitted (AUG-2004) to the EMBL/GenBank/DDBJ databases.
CC -!- FUNCTION: Vimentins are class-III intermediate filaments found in
CC various non-epithelial cells, especially mesenchymal cells. Vimentin is
CC attached to the nucleus, endoplasmic reticulum, and mitochondria,
CC either laterally or terminally.
CC -!- SUBUNIT: Homomer.
CC -!- PTM: One of the most prominent phosphoproteins in various cells of
CC mesenchymal origin. Phosphorylation is enhanced during cell division,
CC at which time vimentin filaments are significantly reorganized.
CC -!- SIMILARITY: Belongs to the intermediate filament family.
CC {ECO:0000255|PROSITE-ProRule:PRU01188}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; X16843; CAA34741.1; -; mRNA.
DR EMBL; BC080051; AAH80051.1; -; mRNA.
DR EMBL; BC085223; AAH85223.1; -; mRNA.
DR PIR; A43549; A43549.
DR RefSeq; NP_001080908.1; NM_001087439.1.
DR AlphaFoldDB; P24789; -.
DR SMR; P24789; -.
DR BioGRID; 98845; 1.
DR IntAct; P24789; 1.
DR PRIDE; P24789; -.
DR DNASU; 386601; -.
DR GeneID; 386601; -.
DR KEGG; xla:386601; -.
DR CTD; 386601; -.
DR Xenbase; XB-GENE-866225; vim.L.
DR OMA; PPMRLHD; -.
DR OrthoDB; 655109at2759; -.
DR Proteomes; UP000186698; Chromosome 6L.
DR Bgee; 386601; Expressed in lung and 19 other tissues.
DR GO; GO:0005882; C:intermediate filament; IEA:UniProtKB-KW.
DR InterPro; IPR018039; IF_conserved.
DR InterPro; IPR039008; IF_rod_dom.
DR InterPro; IPR006821; Intermed_filament_DNA-bd.
DR InterPro; IPR027699; Vimentin.
DR PANTHER; PTHR45652:SF5; PTHR45652:SF5; 1.
DR Pfam; PF00038; Filament; 1.
DR Pfam; PF04732; Filament_head; 1.
DR SMART; SM01391; Filament; 1.
DR PROSITE; PS00226; IF_ROD_1; 1.
DR PROSITE; PS51842; IF_ROD_2; 1.
PE 2: Evidence at transcript level;
KW Coiled coil; Intermediate filament; Reference proteome.
FT CHAIN 1..458
FT /note="Vimentin-1/2"
FT /id="PRO_0000063762"
FT DOMAIN 96..404
FT /note="IF rod"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01188"
FT REGION 1..88
FT /note="Head"
FT REGION 1..27
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT REGION 89..124
FT /note="Coil 1A"
FT REGION 125..146
FT /note="Linker 1"
FT REGION 147..238
FT /note="Coil 1B"
FT REGION 239..261
FT /note="Linker 12"
FT REGION 262..400
FT /note="Coil 2"
FT REGION 401..458
FT /note="Tail"
FT SITE 344
FT /note="Stutter"
FT /evidence="ECO:0000255"
FT VARIANT 43
FT /note="S -> SS (in vim2)"
SQ SEQUENCE 458 AA; 52845 MW; 29A46C76F256AC0C CRC64;
MATTKSSYRR IFGGNPRSSS SGNRYATSST RYTLGSAMRP STSSRMVYST SSSPAVFKSS
SVRLRSSLPP ARMADSVDFA LADAVNLEFK ANRTNEKAEM IELNDRFANF IDKVRFLEQQ
NKILVAELEQ LKGKGTSRIG DLYEEEMREL RRQLDQATND KARVEVDRDN LADDLQRLRE
KLQDEMIQKE EAEGNLQSFR QDVDNASLAR IDLERKVESL QEEIAFLKKL HDEEIRELQL
QIQESHIQVD MDVSKPDLTA ALRDVRQQYE NVAAKNLSDA EEWYKSKFAD LSEAANRNND
ALRQAKQETS DFRRQIQTLT CEIDAMKGSN ESYERQMREM EENFAIEAAN YQDTIQRLQE
EIQNMKEEMA RHLREYQDLL NVKMALDIEI ATYRKLLEGE ESRISLPVHS FSTMSLRETN
LDSHPAETHS KRTVLIKTVE TRDGQVVNES SQHHDDFE